Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Intermediate HCC

Zhongda Hospital · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
hepatocellular-carcinomaimmune-checkpoint-inhibitors
hepatocellular carcinoma, transarterial chemoembolization, immune checkpoint inhibitors, molecular target therapies, intermediate stage, observational
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 868195
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.